MI Visit the ASPET Website
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yonezawa, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yonezawa, K.
Molecular Interventions 3:189-193 (2003)
© 2003 American Society of Pharmacology and Experimental Therapeutics



Viewpoint

Identification of TOR-interacting Proteins

Kazuyoshi Yonezawa

Biosignal Research Center, Kobe University, Kobe 657-8501, Japan, and CREST, Japan Science and Technology Corporation

SUMMARY

The protein kinase mTOR (mammalian target of rapamycin) promotes cell growth by phosphorylating substrates leading to the derepression of mRNA translation. Recently, a number of mTOR-interacting proteins (such as Raptor and GßL) have been characterized, shedding light on the pathway that regulates protein expression and cell growth. Unfortunately, conflicting results have obfuscated the roles of these proteins within the context of the mTOR signaling pathway. Other proteins, such as the tuberous sclerosis complex proteins (TSCs), appear to inhibit the activity of mTOR and thereby prevent the activation of the p70S6 kinase and the eukaryotic initiation factor 4E-binding protein 1. Mutations of mTOR-inhibiting TSCs have in fact been implicated in disease, underscoring the importance of further elucidating the mTOR pathway.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ASPET Journals Pharmacological Reviews Drug Metabolism and Disposition
Molecular Interventions Molecular Pharmacology J Pharmacology and Exp Therapeutics
Copyright © 2003 by the American Society for Pharmacology and Experimental Therapeutics.